Login to Your Account



R&D Makeover

A Deep Dive into Pfizer's Emerging Biotech Strategy

By Arlene Weintraub


Monday, November 29, 2010
On Nov. 16, Pfizer Inc. announced a partnership with the University of California at San Francisco aimed at translating biotechnology discoveries into marketable drugs. It's the newest element of a multifaceted, R&D makeover that's designed to transform the New York-based pharmaceutical giant into a biotechnology powerhouse.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription